We are live on ! Find out more
ATRS

Antares Pharma, Inc.
ATRS

Delisted

ATRS was delisted on the 23rd of May, 2022.

Back to rankings

91 hedge funds and large institutions have $174M invested in Antares Pharma, Inc. in 2014 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more call options, than puts

Call options by funds: $1.03M | Put options by funds: $609K

17% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 12

15% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 26

2% more funds holding

Funds holding: 89 → 91 (+2)

22% less capital invested

Capital invested by funds: $223M → $174M (-$49M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
91
Holders Change
+2
Holders Change %
+2.25%
% of All Funds
2.63%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
14
Increased
30
Reduced
26
Closed
12
Calls
$1.03M
Puts
$609K
Net Calls
+$425K
Net Calls Change
+$28K

Top Buyers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
+$6.66M
2
JGC
J. Goldman & Co
New York
+$3.15M
3
PI
Putnam Investments
Massachusetts
+$2.6M
4
PWAM
Park West Asset Management
California
+$2.22M
5
MIG
Mariner Investment Group
New York
+$1.32M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$6.11M
2
TAM
THB Asset Management
Connecticut
-$3.94M
3
DM
Deerfield Management
New York
-$2.9M
4
HCM
Harvey Capital Management
Florida
-$2.39M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
51
BlackRock Advisors
Delaware
$284K +$19.5K +4,397 +6%
AIG
52
American International Group
New York
$269K +$8.17K +1,841 +2%
State Board of Administration of Florida Retirement System
53
State Board of Administration of Florida Retirement System
Florida
$257K – – –
OC
54
Oppenheimer & Co
New York
$234K -$293K -66,141 -50%
OAM
55
Oxford Asset Management
United Kingdom
$230K +$292K +65,746 New
Principal Financial Group
56
Principal Financial Group
Iowa
$200K +$253K +57,131 New
SCM
57
Stevens Capital Management
Pennsylvania
$193K +$245K +55,258 New
PAA
58
Peregrine Asset Advisers
Oregon
$186K – – –
BAS
59
Brown Advisory Securities
Maryland
$177K – – –
VKH
60
Virtu KCG Holdings
New York
$177K +$155K +34,904 +221%
Bank of America
61
Bank of America
North Carolina
$151K +$173K +38,897 +929%
Citadel Advisors
62
Citadel Advisors
Florida
$149K -$205K -46,278 -52%
ARTA
63
A.R.T. Advisors
New York
$134K +$170K +38,322 New
TDC
64
Thompson Davis & Co
Virginia
$128K – – –
Creative Planning
65
Creative Planning
Kansas
$92K +$106K +24,000 +1,091%
QIM
66
Quantitative Investment Management
Virginia
$91K +$116K +26,200 New
SIC
67
SFE Investment Counsel
California
$87K – – –
PNC Financial Services Group
68
PNC Financial Services Group
Pennsylvania
$73K -$33.8K -7,624 -27%
First Eagle Investment Management
69
First Eagle Investment Management
New York
$70K – – –
NI
70
Numeric Investors
Massachusetts
$66K +$83.9K +18,900 New
Morgan Stanley
71
Morgan Stanley
New York
$60K +$4.93K +1,111 +7%
SG Americas Securities
72
SG Americas Securities
New York
$56K +$70.5K +15,884 New
CI
73
Cowen Inc
New York
$53K – – –
PG
74
PEAK6 Group
Illinois
$50K +$63.7K +14,368 New
CA
75
Corrado Advisors
New Jersey
$48K – – –
1 2
3
4 5

ATRS Hedge Fund Activity: Q1 2014 in Review

91 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Antares Pharma, Inc. (ATRS) for Q1 2014, worth a combined $174M — down 22% from $223M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ATRS positions and 12 closed out — a net gain of 2 holders — while 30 added to existing stakes and 26 trimmed.

The largest buyer was Broadfin Capital, adding an estimated $6.66M. The largest seller was OrbiMed, cutting an estimated $6.11M.

  • 91 institutional investors held Antares Pharma, Inc. (ATRS) as of Q1 2014, up from 89 in Q4 2013.
  • Funds reported $174M of Antares Pharma, Inc. stock for Q1 2014, down 22% quarter-over-quarter.
  • 14 funds opened new Antares Pharma, Inc. positions in Q1 2014 and 12 closed out, a net change of +2 holders.
  • The largest Antares Pharma, Inc. buyer in Q1 2014 was Broadfin Capital, an estimated $6.66M added.
  • The largest Antares Pharma, Inc. seller in Q1 2014 was OrbiMed, an estimated $6.11M sold.

Based on aggregated 13F filings for Q1 2014.